These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3274412)

  • 1. Comparison of oral and intravenous cyclosporine A in kidney transplants.
    Asokan VS; Sweny P; Varghese Z; Moorhead JF; Fernando ON
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1717-8. PubMed ID: 3274412
    [No Abstract]   [Full Text] [Related]  

  • 2. Steady-state concentrations of cyclosporine for therapeutic monitoring.
    Grevel J; Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1339-42. PubMed ID: 2190397
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine--high-dose steroid interaction in renal transplant recipients: assessment by HPLC.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ; Hakala TR; Rosenthal JT; Carpenter BJ; Taylor RJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1728-9. PubMed ID: 3274417
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotransformation of cyclosporin G in comparison to cyclosporine.
    Mangold JB; Schran HF; Yatscoff RW; Weitzel WF; Leichtman AB
    Transplant Proc; 1994 Oct; 26(5):3013-6. PubMed ID: 7940950
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous cyclosporine and kidney function: the Johns Hopkins experience.
    Williams GM; Irwin B; Burdick J; Pennington L
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):66-8. PubMed ID: 3515697
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of mode of pretransplant loading with cyclosporine on the incidence of early rejection in haploidentical living related donor renal recipients.
    Kahan BD; Wideman C; Gibbons S; Ried M; Jarowenko M; Flechner S; Van Buren CT
    Transplant Proc; 1984 Dec; 16(6):1619-23. PubMed ID: 6390876
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the safety and efficacy of oral vs constant-rate intravenous infusion cyclosporine immediately following orthotopic heart transplantation.
    Myre SA; Schroeder TJ; Melvin DB; Pesce AJ; Collins JA; Stephens GW; First MR
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2484-6. PubMed ID: 2650310
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonselective measurement of cyclosporine for therapeutic drug monitoring by fluorescence polarization immunoassay with a sheep polyclonal antibody: II. Evaluation of the whole blood methodology and comparison with an 3H tracer-mediated radioimmunoassay with a sheep polyclonal antibody.
    Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1181-5. PubMed ID: 2190378
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimization by timing of oral cyclosporine to prevent acute kidney allograft rejection in dogs.
    Cavallini M; Halberg F; Sutherland DE; Cornélissen G; Heil J; Najarian JS
    Transplantation; 1986 May; 41(5):654-7. PubMed ID: 3518168
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine pharmacokinetics in the early course of renal transplantation.
    Albrecht K; Niebel W; Marggraf G; Eigler FW
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1719. PubMed ID: 3274413
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacokinetics of cyclosporine A in uremic patients.
    Lindberg A; Odlind B; Tufveson G; Lindström B; Gabrielsson J
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):144-52. PubMed ID: 3787709
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine A monitoring by radioimmunoassay (RIA) and high-performance liquid chromatography (HPLC) after liver transplantation: influence of route of administration and of liver function on the RIA:HPLC ratio.
    Oldhafer KJ; Schumann G; Wonigeit K; Oellerich M; Ringe B; Pichlmayr R
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):361-5. PubMed ID: 3291268
    [No Abstract]   [Full Text] [Related]  

  • 13. The long-term deleterious effect of delayed graft function in cyclosporine-treated renal allograft recipients.
    Rocher LL; Landis C; Dafoe DC; Keyserling C; Swartz RD; Campbell DA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2093-5. PubMed ID: 3274476
    [No Abstract]   [Full Text] [Related]  

  • 14. Minimal low dosage of cyclosporine therapy in renal transplantation by careful monitoring of high-performance liquid chromatography whole blood trough levels.
    Uchida K; Yamada N; Orihara A; Tominaga Y; Tanaka Y; Hayashi S; Kondo T; Morozumi K; Satake M; Taira N
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):394-401. PubMed ID: 3284083
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of five cyclosporine-prednisone regimens for induction of immunosuppression in cadaveric kidney recipients: a retrospective analysis of 245 cases.
    Kahan BD; Lorber MI; Flechner SM; Van Buren CT; Jensen C; Wideman CA
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):59-65. PubMed ID: 3515696
    [No Abstract]   [Full Text] [Related]  

  • 16. Two immunosuppressive drug regimens after renal transplantation: low dosage of cyclosporine adjusted on the basis of high-performance liquid chromatography whole blood levels and prednisone.
    Uchida K; Orihara A; Yamada N; Tominaga Y; Kawai M; Tanaka Y; Morozumi K; Hayashi S; Satake M; Taira N
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):401-5. PubMed ID: 3279629
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine blood concentrations in the management of renal transplant recipients.
    Rogerson ME; Marsden JT; Reid KE; Bewick M; Holt DW
    Transplantation; 1986 Feb; 41(2):276-8. PubMed ID: 3511588
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine in pediatric liver transplantation: is there a therapeutic blood level that abrogates rejection?
    Margarit C; Martinez Ibáñez V; Potau N; Iglesias J; Boix Ochoa J
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):369-74. PubMed ID: 3291270
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous cyclosporine for heart transplantation.
    Bolman RM; Cance CG
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2488. PubMed ID: 2650312
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.
    Feduska NJ; Melzer J; Amend WJ; Vincenti F; Tomlanovich S; Salvatierra O
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):136-40. PubMed ID: 3515681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.